Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Y-Mabs Therapeutics (YMAB) Debt to Equity (2018 - 2025)

Y-Mabs Therapeutics (YMAB) debt to equity from Sep 30, 2018 to Jun 30, 2025. The current Y-Mabs Therapeutics (YMAB) debt to equity is 3.66%. You can export chart.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Y-Mabs Therapeutics (YMAB)

YearDebt to EquityChange
20243.48%
N/A
20230.00%
N/A
20220.00%
N/A
20210.00%
N/A
20200.00%
N/A
20190.00%
N/A
20180.00%
N/A

Comparison Y-Mabs Therapeutics (YMAB) debt to equity with competitors

Y-Mabs Therapeutics (YMAB) debt to equity is 3.66%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-99.27%
ARVNArvinas Inc0.13%-96.47%
GHRSGH Research PLC0.16%-95.52%
ATHEAlterity Therapeutics Ltd0.18%-95.04%
CGONCg Oncology Inc0.27%-92.49%
PHVSPharvaris NV0.31%-91.45%
OSRHBellevue Life Sciences Acquisition Corp0.37%-89.92%
GLPGGalapagos NV0.37%-89.78%
VTVTvTv Therapeutics Inc - Class A0.46%-87.42%
BDRXBiodexa Pharmaceuticals Plc0.53%-85.38%
LPTXLeap Therapeutics Inc0.68%-81.41%
CMNDClearmind Medicine Inc0.74%-79.64%
CBUSCibus Global Ltd. Class A0.75%-79.43%
ABVCABVC BioPharma Inc0.82%-77.48%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-76.12%
PPCBPropanc Biopharma Inc1.05%-71.23%
ARGXArgen X SE1.14%-68.83%
OCSOculis Holding AG1.14%-68.75%
XRTXXORTX Therapeutics Inc1.17%-67.94%
IMMPImmutep Ltd1.22%-66.56%
CANFCan-Fite Biopharma Ltd1.27%-65.29%
RVPHReviva Pharmaceuticals Holdings Inc1.33%-63.74%
BNTXBioNTech SE1.62%-55.72%
NBPNovaBridge Biosciences.1.74%-52.31%
NRXSNeuraxis Inc1.75%-52.08%
IMABI-Mab1.77%-51.61%
IFRXInflaRx N.V.2.23%-39.00%
ONCOOnconetix Inc2.47%-32.52%
ENTOEntero Therapeutics, Inc. Common Stock2.51%-31.38%
GANXGain Therapeutics Inc2.67%-27.09%
NCNANuCana plc3.04%-16.88%
ADXNAddex Therapeutics Ltd3.11%-14.93%
SXTP60 Degrees Pharmaceuticals Inc3.29%-10.09%
IMTXImmatics N.V3.31%-9.54%
IRONDisc Medicine Inc4.27%+16.62%
LGVNLongeveron Inc - Class A4.67%+27.60%
MOLNMolecular Partners AG4.89%+33.56%
NCELNLS Pharmaceutics Ltd4.90%+33.87%
ADAGAdagene Inc5.23%+43.05%
PRTCPureTech Health plc American Depositary Shares5.56%+52.12%
ALXOAlx Oncology Holdings Inc5.62%+53.77%
REGNRegeneron Pharmaceuticals Inc6.32%+72.81%
ANROAlto Neuroscience Inc6.58%+79.98%
MDXGMimedx Group Inc7.24%+98.01%
GDTCCytoMed Therapeutics Ltd7.37%+101.60%
MRNAModerna Inc7.96%+117.75%
QLGNQualigen Therapeutics, Inc. Common Stock8.40%+129.66%
BEAMBeam Therapeutics Inc8.60%+135.25%
PBYIPuma Biotechnology Inc8.79%+140.22%
PYPDPolypid Ltd9.00%+146.17%
KURAKura Oncology Inc9.04%+147.07%
SLNOSoleno Therapeutics Inc10.06%+175.01%
VRAXVirax Biolabs Group Ltd - Class A10.13%+176.90%
SVASinovac Biotech Ltd11.15%+204.80%
RIGLRigel Pharmaceuticals11.25%+207.66%
MAZEMaze Therapeutics Inc11.36%+210.72%
ABEOAbeona Therapeutics Inc12.48%+241.18%
CLDICalidi Biotherapeutics Inc12.62%+245.15%
ACIUAC Immune SA13.65%+273.17%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%+299.77%
VERAVera Therapeutics Inc - Class A15.01%+310.52%
ALTAltimmune Inc15.25%+316.83%
NUVBNuvation Bio Inc - Class A16.62%+354.45%
SVRASavara Inc17.08%+366.97%
ACHVAchieve Life Sciences Inc17.21%+370.63%
DYNDyne Therapeutics Inc17.27%+372.11%
HRMYHarmony Biosciences Holdings Inc17.45%+376.97%
SPRBSpruce Biosciences Inc18.66%+410.07%
RCUSArcus Biosciences Inc19.08%+421.77%
INVAInnoviva Inc19.24%+425.95%
MDWDMediWound Ltd19.62%+436.34%
TARSTarsus Pharmaceuticals Inc20.80%+468.80%
XNCRXencor Inc21.05%+475.48%
TCRXTscan Therapeutics Inc22.51%+515.34%
APLSApellis Pharmaceuticals Inc22.59%+517.71%
CNTACentessa Pharmaceuticals plc22.66%+519.58%
BMRNBiomarin Pharmaceutical Inc23.02%+529.49%
TSHATaysha Gene Therapies Inc23.10%+531.59%
FBIOFortress Biotech Inc23.12%+532.07%
MESOMesoblast Ltd23.52%+542.95%
HYFTMindWalk Holdings Corp23.71%+548.37%
ONCBeiGene Ltd24.13%+559.85%
LXRXLexicon Pharmaceuticals Inc24.49%+569.63%
NKTRNektar Therapeutics24.89%+580.56%
ICCCImmucell Corp29.87%+716.63%
CRSPCRISPR Therapeutics AG32.27%+782.15%
ZLABZai Lab Ltd32.30%+783.10%
QUREuniQure N.V.33.44%+814.30%
ABOSAcumen Pharmaceuticals Inc35.49%+870.37%
ALDXAldeyra Therapeutics Inc36.29%+892.28%
PRQRProQR Therapeutics N.V36.40%+895.30%
OBIOOrchestra BioMed Holdings Inc36.41%+895.60%
COGTCogent Biosciences Inc36.72%+904.07%
ELABPMGC Holdings Inc37.62%+928.51%
ASBPAspire Biopharma Holdings Inc38.75%+959.58%
MLTXMoonLake Immunotherapeutics - Class A38.98%+965.73%
LEGNLegend Biotech Corp40.23%+999.90%
PHXMPHAXIAM Therapeutics SA ADR42.62%+1065.38%
PHARPharming Group N.V.43.21%+1081.26%
XFORX4 Pharmaceuticals Inc44.52%+1117.30%
REPLReplimune Group Inc50.14%+1270.78%
ADMAAdma Biologics Inc50.44%+1278.96%
CLGNCollPlant Biotechnologies Ltd New54.22%+1382.30%
BLRXBioline Rx Ltd54.40%+1387.31%
SRPTSarepta Therapeutics Inc55.69%+1422.55%
ARQTArcutis Biotherapeutics Inc57.70%+1477.45%
MDGLMadrigal Pharmaceuticals Inc62.62%+1612.17%
CAICaris Life Sciences Inc - Class A64.29%+1657.82%
SRRKScholar Rock Holding Corp71.23%+1847.57%
INSMInsmed Inc76.93%+2003.21%
ATAIATAI Life Sciences N.V.83.95%+2195.32%
VRNAVerona Pharma Plc87.12%+2281.92%
IONSIonis Pharmaceuticals Inc88.01%+2306.28%
RYTMRhythm Pharmaceuticals Inc88.25%+2312.91%
RPRXRoyalty Pharma plc - Class A90.13%+2364.31%
CDXSCodexis Inc93.64%+2460.09%
ALECAlector Inc94.08%+2472.10%
GMABGenmab94.17%+2474.79%
TTRXTurn Therapeutics Inc97.04%+2553.15%
GERNGeron Corp109.92%+2905.32%
XOMAXOMA Royalty Corp110.48%+2920.73%
TLXTelix Pharmaceuticals Ltd112.45%+2974.56%
HCWBHCW Biologics Inc114.14%+3020.64%
JAZZJazz Pharmaceuticals plc118.15%+3130.17%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%+3161.82%
TGTXTG Therapeutics Inc127.78%+3393.66%
ARDXArdelyx Inc136.94%+3643.92%
FOLDAmicus Therapeutics Inc143.18%+3814.65%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%+3896.45%
AAPGAscentage Pharma Group International149.47%+3986.70%
SLXNSilexion Therapeutics Corp149.83%+3996.40%
OPTOpthea Ltd156.18%+4170.06%
SPRYARS Pharmaceuticals Inc157.44%+4204.45%
NMRANeumora Therapeutics Inc159.82%+4269.66%
MISTMilestone Pharmaceuticals Inc161.42%+4313.45%
CLLSCellectis181.25%+4855.44%
ASNDAscendis Pharma A/S183.75%+4923.92%
FTREFortrea Holdings Inc200.32%+5376.96%
AIMAIM ImmunoTech Inc.215.25%+5784.99%
CELCCelcuity Inc257.58%+6942.52%
HOWLWerewolf Therapeutics Inc262.95%+7089.18%
VALNValneva SE273.15%+7368.15%
ALLRAllarity Therapeutics Inc290.17%+7833.52%
HUMAHumacyte Inc308.59%+8337.16%
AXSMAxsome Therapeutics Inc344.13%+9308.72%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%+11491.88%
PGENPrecigen Inc462.16%+12535.87%
OCGNOcugen Inc502.91%+13649.91%
SNDXSyndax Pharmaceuticals Inc840.90%+22890.77%
HALOHalozyme Therapeutics Inc976.45%+26596.79%
EDITEditas Medicine Inc1240.40%+33813.42%
RVNCRevance Therapeutics Inc1477.84%+40305.07%
IOBTIO Biotech Inc1829.20%+49911.44%